MétaCan
Menu
Back to cohort

O0043 SOYBEAN LECITHIN IMPROVES BILIARY SECRETION AND PROTECTS AGAINST LIVER FIBROSIS IN CHOLESTATIC MDR2 KNOCK‐OUT MICE

2004· article· en· W4390567835 on OpenAlexaff
Thierry Lamireau, Giorgio Bouchard, Haude Clouzeau‐Girard, Ibrahim Yousef, Jean Rosenbaum, Béatriz Tuchweber, Alexis Desmoulière

Bibliographic record

VenueJournal of Pediatric Gastroenterology and Nutrition · 2004
Typearticle
Languageen
FieldMedicine
TopicPediatric Hepatobiliary Diseases and Treatments
Canadian institutionsCentre Hospitalier Universitaire Sainte-Justine
Fundersnot available
KeywordsMedicineHumanitiesArt

Abstract

fetched live from OpenAlex

Introduction: Soybean lecithin has been shown to decrease the development of fibrosis in alcohol- or CCl4-induced liver disease in animals. The aim of the study was to investigate the antifibrotic properties of lecithin in Mdr2 KO mice, a model of cholestatic liver disease in which animals rapidly develop fibrosis when receiving cholic acid. Methods: After weaning, Mdr2 KO mice were divided in 4 separated diet groups of 5–6 animals: control diet (C), control diet + 0.025% cholic acid (CA), soybean lecithin containing diet (L), and soybean lecithin containing diet + 0.025% cholic acid (L+CA). After 2 weeks, blood sample and bile were collected, then animals were sacrificed and liver was excised. Biliary concentrations of bile acids, cholesterol and phospholipid, liver lipid content, and serum liver enzyme levels (ALAT, ALP, GGT) were measured. Histological examination of the liver was performed, using cytokeratin immunostaining for bile duct proliferation, alpha-smooth muscle actin immunostaining for fibroblast activation, BrdU immunostaining for cellular proliferation, and Sirius red staining for fibrosis. A quantification was performed using image analysis. Results: In mice receiving cholic acid (CA), body weight decreased and liver weight increased compared with other groups. Serum liver enzyme levels were markedly increased in mice receiving cholic acid (CA) but remained similar with control (C) when these animals were fed with lecithin (L+CA) (Table1). Bile flow (6.4 + 0.8 vs 4.9 + 1.7 ul/min/100gBW), and secretion of bile acids (211 + 77 vs 154 + 65 mmol/min/100gBW), phospholipid (0.19 + 0.1 vs 0.1 + 0.06 mmol/min/100gBW) and cholesterol (1.35 + 0.8 vs 0.77 + 0.63 mmol/min/100gBW) were increased in group L+CA versus group CA (p<0.01). Liver content of lipids was similar in group CA compared with group C, and was decreased in animals receiving lecithin (groups L and L+CA). Bile duct proliferation, fibroblast activation, cell proliferation in portal tracts, and liver fibrosis, were significantly increased in mice receiving cholic acid (group CA) compared with controls (group C), but remained similar to controls when animals receiving cholic acid were supplemented with lecithin (group L+CA). Conclusion: This study demonstrates that soybean lecithin improves biliary secretion and liver pathology in the Mdr2 KO mice model. These observations lead to propose that clinical trials with lecithin could take place in human cholestatic diseases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.234
Teacher spread0.225 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Pediatric Gastroenterology and NutritionSame topicPediatric Hepatobiliary Diseases and TreatmentsFrench-language works237,207